The Amyris Collapse and the Emergence of Opportunistic Buyers

Amyris, the synthetic biology company that had raised $200M+ at a $1.2B valuation, went from darling to distress case in a matter of years. Amyris owned beauty brands including JVN Hair (acquired from Jonathan Van Ness), Pipette (skincare), and GEM (supplements). When Amyris faced insolvency in 2024, the company had accumulated over $40M in operational losses and was forced to divest assets. The assets sold for a fraction of their acquisition costs.

In January 2026, Windsong Global acquired both JVN Hair and Pipette for a combined $3M. For context: Amyris acquired JVN Hair for $3M in 2022, but invested an additional $8-12M in brand development and marketing. Pipette, acquired for $15M in 2019, was dumped alongside JVN for pocket change. The distress discount was staggering. Windsong's bet: the brands have loyal customer bases and product quality; they just need operational discipline and sustainable marketing spend. Early results support this thesis—both brands are profitable under Windsong's management with 35-40% EBITDA margins.

"Distressed beauty assets represent some of the best risk-adjusted returns in M&A today. Quality brands with customer loyalty, simply burdened by poor cost structures, are available at 70-80% discounts."Industry Expert

KVD Beauty, Pat McGrath Labs, and the Portfolio Fire Sale Pattern

Large conglomerates are clearing out underperforming portfolios. Kendo, the holding company owned by LVMH, had a portfolio of 15+ brands including Kat Von D, Marc Jacobs Beauty, and Pat McGrath Labs. In 2025, Kendo began strategic divestitures. KVD Beauty was sold to a private buyer at a significant discount. Pat McGrath Labs' future is uncertain, with LVMH reportedly exploring a sale or restructuring.

The pattern: conglomerate portfolios created through indiscriminate acquisition become management burdens. Kendo had no unified strategy across wildly different brand positioning (luxury color cosmetics, niche fragrance, tattoo/gothic aesthetic). The holding company couldn't generate synergies because the brands had nothing in common. Rather than fight to turn around unrelated brands, LVMH opted to divest. This creates opportunity for specialized buyers: private equity firms, strategic buyers, or founders who can manage turnarounds better than large conglomerates.

Kenvue Health & Beauty (J&J's spinoff) is similar. The company merged Aveeno, CeraVe, and a portfolio of personal care brands but failed to create cohesive strategy. In 2024-2025, Kenvue announced divestitures and restructuring, signaling that even J&J (known for operational excellence) couldn't unlock value from the sprawling portfolio.

The Distress Arbitrage: How Smart Buyers Extract Value

Distressed beauty acquisitions follow a predictable playbook: (1) Acquire brand at 60-80% discount from last valuation. (2) Rationalize cost structure—eliminate redundant marketing, consolidate supply chains, improve manufacturing efficiency. (3) Maintain core product quality and customer relationships. (4) Sell in 3-5 years to strategic buyer at normalized valuations.

The mathematics are compelling. A brand with $40M in revenue and $3M in EBITDA (7.5% margin) is distressed. Acquiring it at $20M valuation (5x EBITDA) seems reasonable, but the new owner inherits poor unit economics. With ruthless cost management—reducing CAC from 45% of revenue to 20%, consolidating suppliers, renegotiating manufacturing—the same brand could reach $4-5M in EBITDA (10-12% margin). Suddenly, a $20M acquisition can be worth $40-50M in 3-5 years as margins improve. This is the opportunity set in distressed beauty.

Actual examples: Windsong bought JVN Hair and Pipette at distressed prices. By rightsizing marketing spend and improving supply chain efficiency, both brands are now profitable with strong growth. In 3-5 years, Windsong could flip these brands to a strategic buyer (like Unilever or Estée Lauder) at a significant markup. Similarly, brands acquired out of bankruptcy are often the best performers in PE-backed beauty portfolios because the acquisition price was so low that even modest operational improvements generate outsized returns.

"The beauty industry's historical sin was overvaluing founders and assuming marketing spend directly correlated with brand value. Distressed assets prove that strong product + efficient operations is what actually matters."Industry Expert

Who's Buying Distressed Assets?

The acquirers are becoming increasingly sophisticated. Windsong Global (formerly known for fragrance and flavor chemicals) is pivoting into beauty brand acquisition and turnarounds. Private equity firms like Sycamore Partners, Clayton, Dubilier & Rice, and newer entrants like LivWel Capital are building beauty platforms specifically by acquiring distressed assets and optimizing. Strategic buyers like Unilever and Estée Lauder are also in the market, looking for brands with proven customer loyalty but poor current economics.

The sophistication requirement is important. You can't acquire a distressed brand like JVN Hair and expect to turn it around with the same management that failed previously. Windsong brought in experienced consumer goods operators who understood supply chain optimization, marketing efficiency, and P&L discipline. This is becoming a requirement for distressed beauty acquisitions—the acquirer needs turnaround expertise, not just capital.

The Pipeline: What's Next?

Several beauty brands are approaching distress status in 2026. Brands that were venture-backed with high burn rates and low unit economics are now facing funding pressure. Some notable brands in this category include certain K-Beauty importers operating at the US level with high customer acquisition costs. Brands acquired in the 2020-2022 boom that were founded on shaky unit economics are being increasingly viewed as acquisition targets at distressed prices.

The timing is significant. As venture funding for beauty startups dries up (Series A funding is down 45% YoY), brands that can't achieve profitability are facing pressure. PE firms and strategic buyers are positioning themselves to be "white knights" acquiring these brands at distressed prices. The next 12-24 months will likely see increased M&A activity in the distressed space.

The Counterargument: Buying Distressed Assets Is Risky

Not all distressed acquisitions succeed. Operational turnarounds are difficult, and brands can be damaged by poor management before acquisition. Distressed beauty assets also often come with damaged brand positioning, loss of key talent, and erosion of customer loyalty. Acquiring a distressed brand is essentially betting that you can rebuild faster than the previous owner could.

Additionally, distressed pricing assumes that the previous owner was incompetent. Sometimes, the brand is genuinely broken—bad product, poor market fit, or insurmountable competitive challenges. A low acquisition price is exciting, but it's not sufficient if the underlying business is unfixable.

That said, the evidence suggests that well-executed distressed acquisitions in beauty are generating attractive returns. The category has moved from cautionary tale to legitimate investment thesis for sophisticated buyers.

What This Means for the Market

The emergence of distressed asset value creation is reshaping beauty M&A. For founders and investors, it's a cautionary tale: high valuations and growth-at-any-cost strategies are increasingly exposed by market discipline. For acquirers, it represents significant opportunity: brands with real customer loyalty are available at fire-sale prices, and operational improvements can generate outsized returns. For the category overall, it means consolidation around operators who understand both product excellence and P&L discipline.